IndraLab

Statements

Digoxin inhibits IFNB1. 1 / 1

| 1

reach

"We found that ouabain and digoxin, two cardiac glycosides clinically approved to treat congestive heart failure and cardiac arrhythmias XREF_BIBR, are also able to potently inhibit IFNbeta induction, and this inhibition is also dose dependent (XREF_FIG)."

21076398

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Digoxin inhibits IFNB1. 1 / 1

INDRA sources:

Databases

Reading